Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function
- PMID: 26647441
- PMCID: PMC4831135
- DOI: 10.1183/13993003.01083-2015
Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function
Abstract
Sex hormones are linked to right ventricular (RV) function, but the relationship between genetic variation in these pathways and RV function is unknown.We performed a cross-sectional study of 2761 genotyped adults without cardiovascular disease. The relationships between RV measures and single nucleotide polymorphisms (SNPs) in 10 candidate genes were assessed. Urinary oestradiol (E2) metabolites produced by cytochrome P4501B1 (CYP1B1) and serum testosterone were measured in women and men respectively.In African-American (AA) women, the CYP1B1 SNP rs162561 was associated with RV ejection fraction (RVEF), such that each copy of the A allele was associated with a 2.0% increase in RVEF. Haplotype analysis revealed associations with RVEF in AA (global p<7.2×10(-6)) and white (global p=0.05) women. In white subjects, higher E2 metabolite levels were associated with significantly higher RVEF. In men, androgen receptors SNPs (rs1337080; rs5918764) were significantly associated with all RV measures and modified the relationship between testosterone and RVEF.Genetic variation in E2 metabolism and androgen signalling was associated with RV morphology in a sex-specific manner. The CYP1B1 SNP identified is in tight linkage disequilibrium with SNPs associated with pulmonary hypertension and oncogenesis, suggesting these pathways may underpin sexual dimorphism in RV failure.
Copyright ©ERS 2016.
Figures
Comment in
-
Sex differences in pulmonary hypertension: are we cleaning up the mess?Eur Respir J. 2016 Feb;47(2):390-3. doi: 10.1183/13993003.01999-2015. Eur Respir J. 2016. PMID: 26828051 No abstract available.
References
-
- Lahm T, Tuder RM, Petrache I. Progress in solving the sex hormone paradox in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2014;307:L7–L26. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01-HL086719/HL/NHLBI NIH HHS/United States
- N01-HC-95162/HC/NHLBI NIH HHS/United States
- N01 HC095161/HL/NHLBI NIH HHS/United States
- N01 HC095168/HL/NHLBI NIH HHS/United States
- P20GM103652/GM/NIGMS NIH HHS/United States
- R01 HL077612/HL/NHLBI NIH HHS/United States
- N01-HC-95165/HC/NHLBI NIH HHS/United States
- N01 HC095159/HL/NHLBI NIH HHS/United States
- N01-HC-95160/HC/NHLBI NIH HHS/United States
- N01 HC095163/HL/NHLBI NIH HHS/United States
- R01 HL086719/HL/NHLBI NIH HHS/United States
- N01 HC095166/HL/NHLBI NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- N02 HL064278/HL/NHLBI NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- N01-HC-95163/HC/NHLBI NIH HHS/United States
- N01-HC-95168/HC/NHLBI NIH HHS/United States
- N01-HC-95159/HC/NHLBI NIH HHS/United States
- N01 HC095167/HL/NHLBI NIH HHS/United States
- N01-HC-95169/HC/NHLBI NIH HHS/United States
- N01-HC-95164/HC/NHLBI NIH HHS/United States
- P20 GM103652/GM/NIGMS NIH HHS/United States
- UL1-TR-000040/TR/NCATS NIH HHS/United States
- N01-HC-95161/HC/NHLBI NIH HHS/United States
- UL1 TR000040/TR/NCATS NIH HHS/United States
- N01 HC095162/HL/NHLBI NIH HHS/United States
- UL1-TR-001079/TR/NCATS NIH HHS/United States
- N01-HC-95166/HC/NHLBI NIH HHS/United States
- N01 HC095165/HL/NHLBI NIH HHS/United States
- K24 HL103844/HL/NHLBI NIH HHS/United States
- N01 HC095164/HL/NHLBI NIH HHS/United States
- N01-HC-95167/HC/NHLBI NIH HHS/United States
- N01 HC095160/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources